Type 2 diabetes is a condition that can cause the body to lose control of the amount of glucose in the blood. The body doesnt respond to insulin properly and may not produce enough, causing a persons blood glucose level to rise too high. If the condition is left untreated, serious complications can arise, including kidney failure, nerve damage, foot ulcers, heart disease and stroke. A persons risk of developing type 2 diabetes is heightened by eating a poor diet, so to manage blood sugar levels its important to eat a healthy diet.

Experts say theres nothing that cannot be eaten if a person has type 2 diabetes, but certain foods should be limited.

You should eat a wide range of foods, including fruit, vegetables and some starchy foods like pasta, and keeping sugar, fat and salt to a minimum.

Its also important to eat breakfast, lunch and diner every day, not to skip meals.

But when it comes to arguably the most important meal of the day, breakfast, what foods are considered best for blood sugar levels?

Bread is a popular breakfast staple, but certain types of bread have been found to be better for blood sugar levels than others.

Foods high in carbohydrate can cause blood sugar levels to spike, and bread is generally very high in carbohydrate.

Another food to consider eating for breakfast is avocado.

Avocado has become a popular breakfast food over the last few years, but has also been shown to be beneficial to blood sugar levels.

Firstly, the creamy green fruit is low in carbohydrates, which means they have little effect on blood sugar levels.

A study published in Nutrition Journal evaluated the effects of adding half an avocado to the standard lunch of healthy, overweight people.

The researchers found avocados do not significantly impact blood sugar levels.

The rest is here:
Type 2 diabetes: Best bread to eat at breakfast to lower blood sugar - Express

Medtronic plc MDT recently partnered with global healthcare company Novo Nordisk A/S in the growing diabetes management space. Through this collaboration, the company aims at developing solutions to incorporate insulin dosing data from future Novo Nordisk smart insulin pens into its own Continuous Glucose Monitoring (CGM) devices like the Guardian Connect system.

More About the Collaboration

This deal with Novo Nordisk, the worlds largest producer of insulin, will help in streamlining the distribution of two of the most vital pieces of information required for diabetes management glucose measurements and insulin dosed.

By combining glucose monitoring and insulin dosing data, diabetes patients as well as their healthcare professionals and caregivers will be able to automatically keep a tab on these two crucial items in a single place, thereby easing the process of diabetes management. This new technology can offer productive insights, thereby ensuring that patients and doctors make more informed decisions on how to manage glucose levels and elevate Time in Range.

In 2020, Novo Nordisk is set to launch durable smart insulin pens, NovoPen 6 and NovoPen Echo Plus, as well as its disposable pre-filled injection solution. The Guardian Connect system will be updated as well to incorporate data from these Novo Nordisk smart pens.

Market Prospects

Per Research and Markets.com, the global diabetes care market is estimated to reach a worth of$95.10 billionby 2023, at a CAGR of 5.53% during the forecast period of 2017-2023. Hence this collaboration is well-timed.

Recent Developments

Lately, Medtronic has been investing in several key developments in order to strengthen its Diabetes Group.

In September, Medtronics the Envision Pro CGM system a fully disposable, zero calibration professional CGM systemhas attained CE Mark approval.The company is on track to commercially release the new system inEuropeand theMiddle Eastlater this year. This new technology is expected to enable patients of either type 1 or type 2 diabetes to monitor accurate glucose levels and trends over time so that more optimal diabetes treatment plans can be formulated accordingly.

In June 2019,Medtronic and Tidepool, a 501(c)(3) nonprofit organization specializing in diabetes management, partnered to create an interoperable automated insulin pump system. Under this collaboration, Medtronic will be developing a Bluetooth-enabled MiniMed pump that would be compatible with Tidepool Loop, an open source automated insulin delivery app which is currently in the process development.

Story continues

Price performance

The stock has rallied 12.5% in the past year compared with theindustrys 1.3% dip.

Zacks Rank and Other Stocks Worth a Look

Medtronic carries a Zacks Rank #2 (Buy).

A few other top-ranked stocks in the broader medical space are Haemonetics HAE, Baxter BAX and Amedisys AMED, each carrying a Zacks Rank #2.You can seethe complete list of todays Zacks #1 Rank (Strong Buy) stocks here.

Haemonetics long-term earnings growth rate is expected to be 13.5%.

Baxters long-term earnings growth rate is projected at 12.8%.

Amedisys long-term earnings growth rate is expected to be 16.26%.

5 Stocks Set to Double

Zacks experts released their picks to gain +100% or more in 2020. One is a famous cutting-edge food company that is hiding in plain sight. Swamped with competitors and ignored by Wall Street, its stock price floundered. Now, suddenly, it acquired a company that gives it an advantage none of its peers have.

Today, see all 5 stocks with extreme growth potential >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportMedtronic PLC (MDT) : Free Stock Analysis ReportHaemonetics Corporation (HAE) : Free Stock Analysis ReportBaxter International Inc. (BAX) : Free Stock Analysis ReportAmedisys, Inc. (AMED) : Free Stock Analysis ReportTo read this article on Zacks.com click here.

View post:
Medtronic Collaborates With Novo Nordisk for Diabetes Care - Yahoo Finance

GOLDEN, Colo. -- Sometimes the best ideas are are born out of necessity. And in this case, a sixth-grader from Golden decided to do something when she saw a need for more pockets in her clothing. Sabrina Streich was diagnosed with Type 1 diabetes when she was 8 years old.

She's always been active and she wears a Dexcom G6 continuous glucose monitor to keep tabs on her blood-sugar levels. The monitor sends information to her phone and her parents so they always know how she's doing. She will soon be wearing an insulin pump too and realized it was hard to hide all the devices in her clothing.

"Thats why I wrote Athleta telling them I need more pockets because girls just in general dont have pockets in their clothes and we need more pockets, just as much as the boys do," said 11-year-old Streich.

Streich wrote a letter to the Gap-owned active wear brand Athleta. She also included a sketch of a sweatshirt that showed extra pockets. She was shocked when she received a letter back that was signed by several designers at the company.

"And later they talked to me saying they wanted to make my sweatshirt. 'Are you available to come on this conference call to talk about it?' And I was really excited because normally big companies like that dont respond to letters," said Streich.

During her first ever conference call, she said they asked her questions about the design like how big she wanted the pockets to be. They also asked about her favorite colors.

The company had one more question for her, they asked if she would like to fly to San Francisco to model the sweatshirt for an upcoming catalog. Streich flew out to California with her mom and modeled the sweatshirt that she helped create. It was a true dream come true.

"That was really cool because I just wrote this letter and now they want me to model my sweatshirt," said Streich.

Streich was celebrating her 11th birthday when Denver7 interviewed her at school. She plans to continue celebrating on Sept. 15, when a group of friends will join her for a walk to support the Juvenile Diabetes Research Foundation. The inspiring little girl has already raised $5,000 for her team, the Golden Glucose Warriors.

She beams when she thinks about the fact that her letter to a major company made a difference. She hopes the sweatshirt will help other girls with Type 1 diabetes and she hopes her story will show other kids what they can do.

"I think kids, girls, boys we can do anything," said Streich.

Athleta chose a fitting name for the sweatshirt. It's called "Own Your Power" and surely someone at the company must have been thinking about this sixth-grader when they picked the name.

"I think I owned my power and wrote this company with my power to tell them that girls need pockets," said Streich.

See the article here:
Colorado sixth-grader inspires major clothing company to create diabetes-friendly design - The Denver Channel

That was the description of diabetes by the late Dr. Edgar A. Haunz of Grand Forks, who was chosen in 1975 as the Outstanding Diabetes Clinician in the United States.

In fact, diabetes is a metabolic disorder and a disease, says Dr. Casey Ryan, one of the physicians here who has followed the late Dr. Haunz in caring for diabetics.

Other diabetes physicians who followed Dr. Haunz over the years have included Dr. Robert Warner, Dr. James Brosseau, Dr. William Zaks and Dr. Eric Johnson. Dr. Lori Sondreal manages pediatric diabetes. The physicians have had the help of nurse educators and dietitians in the Altru Diabetes Center started by Dr. Brosseau.

Diabetes treatment has advanced tremendously since the days of Dr. Haunz, according to local doctors. Finger stick testing began in the late 1970s. Now devices can monitor sugars without the need for stick testing. Insulin pumps began in the 1990s, and now pumps can measure blood sugar and deliver insulin.

Dr. Haunz was unique in caring for diabetes when he came to Grand Forks in 1947, according to Dr. Ryan. It was difficult to manage Type 1 diabetes patients taking five shots of insulin daily one with each meal, one at bed time as well as at 3 a.m. There were no blood tests, other than in a hospital or clinic, he said. Patients could do primitive tests at home to assess urine sugar. And in essence, Dr. Haunz was using an insulin pump type treatment.

The rest of the world did not catch up to Dr. Haunz until the late 1970s or early 1980s, Dr. Ryan said. Because of his excellent care, there are many individuals who lived with Type 1 diabetes for more than 50 years.

And this, Dr. Ryan said recently, is considered amazing and a tribute to Dr. Haunz.

Type 1 diabetes can occur at any age, but the most common onset is between 8 and 15 years of age, according to Dr. Ryan.

Usual symptoms are weight loss, thirst and frequent urination, he said. If not diagnosed, high sugars can lead to nausea and vomiting with a condition known as ketoacidosis requiring hospitalization.

The latest technology with blood testing can prevent low blood sugars and help avoid high blood sugars. Dr. Ryan said. This is a life changing treatment for those who have lived with severe low sugar reactions that can cause confusion or seizures.

Doctors find a serious problem now is the epidemic of Type 2 diabetes mellitus. This is due to obesity and can occur at any age. In Type 2 diabetes, the pancreas cannot produce enough insulin to overcome the negative effects of obesity. Most people with Type 2 diabetes make too much insulin, but not enough to keep blood sugars normal. If weight loss occurs the insulin production comes into balance with body requirements.

Diabetes is diagnosed if sugars are over 125 percent of milligrams consistently. Pre-diabetes is the term for persons at increased risk for future diabetes with sugars ranging from 100 to 125 milligram percentage. Normal fasting sugar is 70 to 99 milligrams.

Both Type 1 and Type 2 diabetes are inherited, Dr. Ryan said. Type 1 cannot be prevented yet. Type 2 can be prevented with good diet, exercise and staying within 15 percent of ideal body weight.

Prevention is extremely important, according to doctors. They say uncontrolled diabetes can lead to kidney failure requiring dialysis, blindness, leg amputation, heart attack, stroke and increased infections.

It has been reported that 68,000 in North Dakota have diabetes. Another 180,000 are termed as pre-diabetic.

With all of the problems, Dr. Ryan says the treatment is good. He talks of the progress in monitoring blood sugar. Patients can tell if their percentage is in the 70 to 100 range. High sugar is 150.

A lot of people arent aware of it with all the obesity, Ryan said. The reading of 100 to 125 percent is considered pre-diabetic.

Being within 15 percent of ideal body weight is best. Dr. Ryan is concerned about the huge underlying problem of diabetes. More than 90 percent of people with diabetes are Type 2.

Most diabetes reflected by high readings can be reduced by losing weight. And most Type 2 diabetes is caused by overweight conditions.

Dr. Ryans concern about diabetes stems from the high incidence. He cares, just as others who treat diabetes. His thoughts to back to the words of the late Dr. Haunz. He would point out that with proper treatment, a diabetic can live a longer, more successful and relatively normal life than a person with any other human disorder.

Looking back, Dr. Ryan says a thank you is due to Dr. Haunz for the care he started in Grand Forks and this region.

And the thanks, Dr. Ryan says, goes also to physicians, diabetes educators and dietitians who have followed in the path of Dr. Haunz.

Original post:
Marilyn Hagerty: Learning about how diabetes treatment has changed over time - Grand Forks Herald

The UW Medicine Diabetes Institute celebrated the opening Sept. 10 of new UW Medicine South Lake Union facilities that bring basic science, clinical research, education, and patient care into proximity.

Members of the Institute are from many different fields. Among their varied goals are understanding how the different forms of diabetes emerge, why the condition harms many parts of the body, and what might be done better to prevent or treat diabetes and its serious complications. These can include vision loss, problems for expectant moms and their babies, peripheral nerve damage, infection risks, feet and hands that are injury-prone, kidney disease and heart disease.

People with diabetes have blood sugar levels that rise too high. Its diagnosed by measuring the percentage of sugar-coating on the proteins that carry oxygen in the blood. Type 1 diabetes is thought to be, at least in part, an immune disease that destroys cells in the pancreas that secrete insulin. Insulin helps cells turn certain sugars into energy.

People with Type 2 diabetes either do not make insulin well or their cells dont use it properly. Other forms of diabetes can occur during pregnancy, can be induced by steroid medications, or can be atypical presentations of the disease.

Dr. Michael Schwartz and Dr. Stephanie Page, both professors of medicine in the Division of Endocrinology, co-direct the UW Medicine Diabetes Institute. The UW School of Medicines national leadership in diabetes research, training and care goes back historically to the late 1940s to the first chair of medicine, noted endocrinologist Dr. Robert H. Williams.

As for the formation of the UW Medicine Diabetes Institute, Schwartz and Page said at the opening that it was over six years in the making and is the culmination of efforts of numerous colleagues and supporters.

Diabetes researchers collaborating with UW Medicine Diabetes Institute come not only from the UW health sciences schools, but also from the Puget Sound Veterans Administration, Seattle Childrens, and several other medical and research institutions.

The main components of the UW Medicine Diabetes Institute are:

Metabolism Program, headed by Gregory Morton, research professor of medicine

Pancreatic Islet Cell Program, headed by Rebecca Hull, research associate professor of medicine

Clinical Research Unit, headed by Ellen Schur, associate professor of medicine, General Internal Medicine

Complications of Diabetes Program, headed by Karin Bornfeldt, professor of medicine

Multidisciplinary Clinics, directed by Subbulaxmi Trikudanathan

Patient front entrance to UW Medicine South Lake Unionbuilding housing the Diabetes Institute research and clinical areas.

A few of the numerous examples of what UW Medicine diabetes researchers and clinicians are especially noted for are:

What controls body weight? Because excess an excess body mass index and food choices are among the factors that can contribute to the onset some forms of diabetes, and make it difficult to control after diagnosis, the complex topics of what controls food intake, what influences body weight, and why a healthy weight can be difficult to maintain are covered in many research projects. These include brain mechanisms that promote hunger or fullness, as well as those involved in sensing and protecting fat stores, chemicals that might influence these mechanisms , why some cancers result in loss of body fat and muscle strength, how overeating might damage weight control mechanisms in the brain, and what appears in imaging scans of the brain in anticipation of a meal.

How can obesity be treated? Several studies have been undertaken to find useful answers for this often difficult-to- manage condition, including the effects of bariatric surgery on weight and diabetes control, and the search for new medications that might help in weight reduction without causing intolerable side effects.

How do cells that secrete insulin work, and can lost or damage be restored by stem-cell derived pancreas cells? Basic biochemistry research on the formation and activation of secretory granules in cells, and projects in regenerative medicine, are setting new directions in the science of diabetes, and may point to potential therapeutics.

The role of mitochondria in diabetes and its complications: Researchers are looking problems stemming from the actions of mitochondria which scientists have found have many more functions beyond being power stations in cells in the development of diabetes and its sequels, such as the weakening of the heart.

Can kidney damage from diabetes be reversed? Diabetes is one of the leading causes of kidney failure and the need for dialysis or organ transplant. Studies are underway in small animal models to see if kidney problems can be repaired.

In clinical care, among areas of special note are:

Helping people with diabetes who also have depression or anxiety: Mood disorders can contribute to poor control of diabetes, to diabetes care burnout. The condition can also provoke diabetes distress, a feeling of denial, fear, guilt, and worry, and a sense of the burden of disease management. Depression is more common in people with diabetes, and also can increase their risk of dementia, according to studies conducted by UW School of Medicine researchers. UW Medicine has been a longstanding leader in the mental health support of people with diabetes.

Growing into adulthood with childhood-onset diabetes: UW Medicine and Seattle Childrens pediatric, adolescent and adult medicine physicians, social workers and other counselors have taken a special interest in helping older teens transition into adult diabetes care. Research and experience has shown that, as older teens move on to college or employment, they sometimes do not receive the medical care or diabetes management assistance they need as independent young adults. Transition services help older teens with diabetes navigate challenges with school and jobs, driving, relationships, and insurance and financial issues, such as medication costs and food insecurities. The Adolescent and Young Adult Clinic are headed by pediatrician Kate Weaver and internist Faisal Malik.

The keynote speaker at the opening was Dr. Rudy Leibel from the Naomi Berrie Diabetes Center and Columbia University in New York City. He exhorted current diabetes investigators, clinicians and trainees to think big in their goals, to watch for unexpected talent, and to not let the limitations of current technologies stand in the way of dreams for the future of diabetes research and clinical advances.

People over age 18 with and without diabetes will soon have the chance to join the COVERED Registry as Community Volunteers Engaged in Research to End Diabetes. The directory will connect people interested in learning about new and ongoing opportunities to become research participants with researchers studying diabetes and related disorders. Stay tune for details.

See the article here:
Diabetes Institute celebrates opening - UW Medicine Newsroom

Type 2 diabetes means a persons pancreas doesnt produce enough insulin to control rising blood sugar levels. Over time, rising blood sugar levels can raise a persons risk of developing heart disease and stroke. Luckily, as the condition is strongly tied to poor lifestyle choices, making healthy tweaks can help to bring blood sugar levels under control. Evidence suggests a certain ingredient may do the trick.

One study found that that consuming garlic could help reduce levels of blood sugar in people suffering from type 2 diabetes, as well as offering other benefits in the treatment of the metabolic condition.

Although the research recommended using garlic for reducing blood sugar levels only under the guidance of a persons doctor, it could provide a range of benefits for diabetics in conjunction with their usual treatments of insulin and diet.

It is know that garlic contains more than 400 chemical components, many of which can help prevent and treat a diverse range of health problems, but it is compounds including allicin, allyl propyl disulfide and S-allyl cysteine sulfoxide that raise insulin levels in the blood through the prevention of the liver's inactivation of insulin, so that more insulin is available in the body.

The scientists found that moderate amounts of garlic supplements could offer benefits to diabetes patients, and that raw or cooked garlic or aged garlic extract can help to regulate blood glucose and potentially stop or lower the effects of some diabetes complications, as well as fighting infections, reducing bad cholesterol and aiding blood flow.

However, it is advised that the consumption of garlic could cause side effects for some people, or for those taking it in extreme amounts, noted the study researchers.

Mounting evidence suggests people with type 2 diabetes should generally stick to a low-carb diet.

Diabetes.co.uk recommended following a keto diet.

A keto diet is a very low-carb diet, considered to be when people eat a level of carbohydrate of around 30g of carbohydrates per day or below.

This encourages the body to get its energy from burning body fat which produces an energy source known as ketones, explained the health site.

On a keto diet, blood glucose levels are kept at a low but healthy level which encourages the body to break down fat into a fuel source known as ketones, noted the health body.

It said: The process of breaking down or burning body fat is known as ketosis.

People on insulin will typically require smaller doses of insulin which leads to less risk of large dosing errors.

The diet helps burn body fat and therefore has particular advantages for those looking to lose weight, including people with prediabetes or those otherwise at risk of type 2 diabetes.

A keto diet usually consists of low carbohydrate, moderate protein and high fat.

According to Dr Oz: The fats should be healthy ones like avocado, olive oil, and nuts. The protein should be lean meat, fish, or legumes. And the carbs you consume should come mostly from vegetables.

The NHS also advises that people aim for at least 2.5 hours of exercise a week to also stave off the risks.

What are the symptoms of type 2 diabetes?

According to the NHS, symptoms of type 2 diabetes include:

Go here to see the original:
Type 2 diabetes: Eating this herb could lower blood sugar - Express

Irish medtech company Bluedrop Medical has secured 1.2 million in a seed investment round to bring the total raised by the start-up this year to 3.7 million.

The Galway-headquartered company, which was also awarded a 2.5 million European Innovation Council in June, is developing and commercialising an internet of things-enabled device for early detection of diabetic foot ulcers.

This is a medical issue which results in hundreds of thousands of amputations worldwide each year.

In Ireland alone more than 540 amputations are carried out on patients with diabetes each year as a result of foot ulcers caused by nerve damage. Bluedrop believes its device could save the Irish health service 40 million a year on treatments associated with diabetic foot ulcers.

Company founders Simon Kiersey and Chris Murphy estimate the total worldwide market for its device to be more than 3 billion.

The temperature-monitoring device allows for high-risk patients to be easily tested on a daily basis to see if they are showing signs of a developing ulcer. The device performs a daily scan of a patients feet and sends the data to the cloud for analysis through advanced algorithms capable of detecting abnormalities. By detecting skin damage early, thousands of potential amputations could be avoided.

The company secured the new seed investment in a round led by the angel investor network HBAN, a joint initiative of Intertrade Ireland and Enterprise Ireland.

HBANs MedTech Syndicate has invested 340,000 in total with one of its investors, Dr Colin Henehan, also joining Bluedrops board. Other participants in the seed round include Enterprise Ireland and the Western Development Commission.

The newly-secured funds are to be used to enable Bluedrop to further develop its device, carry out clinical trials and bring its product to market in Europe and the United States. The start-up also intends to boost headcount to 10 people.

When we started doing our due diligence on Bluedrop Medical, we were very impressed by the focus and drive of the team and the size of the market that they will be tapping into. Chris and Simon have developed a class-leading device for early ulcer detection, resolving a huge unmet clinical need, said Dr Henehan, who has more than 20 years experience in the pharmaceutical and medtech industries.

Read more:
Bluedrop Medical raises 1.2m in seed fund for diabetes device - The Irish Times

DUBLIN--(BUSINESS WIRE)--The "Europe Diabetes Care Devices Market to 2027 - Regional Analysis and Forecasts by Product; End User; and Country" report has been added to ResearchAndMarkets.com's offering.

The Europe diabetes care devices market is expected to reach US$ 11,184.6 Mn in 2027 from US$ 6,853.3 Mn in 2018. The market is estimated to grow with a CAGR of 5.7% from 2019-2027.

The growth of the diabetes care devices market is primarily attributed to the rising incidence of diabetes and rising adoption of insulin injection pens over traditional syringes & vials. However, availability of alternatives for drug delivery and reuse of pen needles are likely to pose a negative impact on the market growth. On the other hand, increasing launch of GLP-1 analogues is likely to have a positive impact on the growth of the Europe diabetes care devices market in the coming years.

Glucagon like Peptide-1, also known as GLP-1, is a hormone produced in the gut that is released in response to the food consumed by an individual. The peptide reduces the appetite of an individual and helps to secrete insulin in the body among obese patients. In recent years, external injection of GLP-1 has been witnessing a significant traction due to increase in the number of doctor prescription for these hormones. The rising number of novel GLP-1 analogue launches is thus expected to indirectly provide opportunities for the manufacturers to develop therapy specific pen needles with incorporation of features such as bore size, length and material that is not reactive with the biologic.

In 2018, the glucose monitoring devices segment held a largest market share of 53.9% of the diabetes care devices market, by product. The glucose monitoring devices is expected to dominate its market share in 2027 owing to the rise in the prevalence of the diabetes and presence of the several market players that offers technically advanced products. The testing strips segment among the glucose monitoring devices is anticipated to witness the fastest growth rate of 6.6% during the forecast period, 2019 to 2027 owing to the enormous usages in the glucose monitoring devices.

In 2018, the homecare held a largest market share of 59.8% of the diabetes care devices market, by end user. This segment is also expected to dominate the market in 2027 owing to the rise in the demand for the glucose monitoring devices and insulin delivery devices. Increasing diabetic population, the ease of use, availability, and accessibility of insulin delivery devices has also increased the adoption of self-administration among patients is anticipated to grow at a steady rate during the forecast period. Also the homecare segment is also expected to grow at the fastest growth rate of 5.9% during the forecast period, 2019 to 2027.

Key Topics Covered:

Part 1. Introduction

Part 2. Europe Diabetes Care Devices Market - Key Takeaways

Part 3. Europe Diabetes Care Devices Market - Market Landscape

3.1 Overview

3.2 Market segmentation

3.3 PEST Analysis

Part 4. Europe Diabetes Care Devices Market - Key Market Dynamics

4.1 Key Market Drivers

4.1.1 Rising Incidence of Diabetes

4.1.2 Rising Adoption of Insulin Injection Pens Over Traditional Syringes and Vials

4.2 Key Market Restraints

4.2.1 Availability of Alternatives for Drug Delivery

4.2.2 Reuse of Pen Needles

4.3 Key Market Opportunities

4.3.1 Increasing Launch of GLP-1 Analogues

4.4 Future Trends

4.4.1 Rapid Adoption of Safety Pen Needles Over Standard Pen Needles

4.5 Impact analysis

Part 5. Diabetes Care Devices Market - Europe Analysis

5.1 Market Revenue Forecasts and Analysis

5.2 Market positioning

5.3 Performance of Key Players

5.3.1 Medtronic

5.3.2 F. Hoffmann-La Roche Ltd.

Part 6. Europe Diabetes Care Devices Market Analysis - By Product

6.1 Overview

6.2 Europe diabetes care devices Market by Product, 2018 & 2027 (%)

6.3 Revenue And Forecasts to 2027, By Product (US$ Mn)

6.3.1 Europe Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

6.3.2 Europe Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

6.4 Glucose Monitoring Devices Market

6.4.1 Overview

6.4.2 Europe Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)

6.4.3 Glucometers Market

6.4.4 Lancets Market

6.4.5 Testing Strips Market

6.4.6 Other Glucose Monitoring Devices Market

6.5 Insulin Delivery Devices Market

6.5.1 Overview

6.5.2 Europe Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)

6.5.3 Insulin Pens Market

6.5.4 Insulin Syringes Market

6.5.5 Insulin Pumps Market

6.5.6 Other Insulin Delivery Devices Market

Part 7. Europe Diabetes Care Devices Market Analysis - By End User

7.1 Overview

7.2 End User, 2018 & 2027 (%)

7.3 Market Revenue And Forecasts to 2027, By End User (US$ Mn)

7.4 Homecare Market

7.5 hospitals & Clinics Market

Part 8. Europe Diabetes Care Devices Market Revenue And Forecasts To 2027

Part 9. Diabetes Care Devices Market - Industry Landscape

9.1 Overview

9.2 Comparative Company Analysis

9.3 Growth Strategies done by the companies in the Market, (%)

9.4 Organic Developments

9.5 Inorganic developments

Part 10. Diabetes Care Devices Market-Key Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/oaego3

More:
European $11.18 Bn Diabetes Care Devices Market to 2027 - ResearchAndMarkets.com - Business Wire

THE number of under-40s with diabetes has rocketed by a third in 20 years as a result of the obesity crisis.

Younger adults now make up 12.5 per cent of cases compared to 9.5 per cent in 2000, a study shows.

1

Experts warn those in the age group are more likely to be fat, have poor blood-sugar control and high bad cholesterol.

Researchers also found new diagnoses of Type 2 diabetes in those aged 41 to 50 went up from 14 per cent to 17.5 across the two decades.

The findings by Australian scientists looking at 340,000 new NHS cases were presented at an annual meeting of the European Association for the Study of Diabetes in Barcelona.

Professor Sanjoy Ketan Paul, from Melbourne University, said inactivity, poor diet and obesity are fuelling the rise in young adults with the condition.

He added: People are increasingly stuck in front of TVs and phones, and eating junk food. This lazy lifestyle causes obesity and inactivity, which raises Type 2 diabetes risk.

We need to pick up cases earlier and treat them more intensively.

There are 3.7million Brits with diabetes double the number from two decades ago.

Experts estimate a million more are unaware they have the disease, taking the true total closer to 5 million.

Last month, The Sun teamed up with The Low Carb Program to publish a revolutionary eating plan aimed at combating type 2 diabetes.

Doc's top tips on preventing type 2 diabetes

A few simple lifestyle changes could prevent you from developing type 2 diabetes.

GP Dr Dawn Richards, from VitalityHealth, says: "Living a healthier and more active lifestyle can delay or event prevent the onset of Type 2 diabetes."

She offered her five top tips to help mitigate the risk of developing the condition...

1. Get active

Working your muscles more often and making them work harder improves their ability to use insulin and absorb glucose.

Your goal should be to introduce 30 minutes of physical activity that makes you sweat and breathe a little harder most days of the week.

2. Eat well

Following a Mediterranean or other heart-healthy diet can help reduce your risk of developing diabetes.

The type of carbohydrates you eat as well as serving size is key.

Focus on whole grain carbs instead of starchy carbs since theyre high in fibre and digested slowly, keeping blood sugar levels more even.

3. Control your blood pressure

Most people can do this with regular exercise, a balanced diet and by keeping a healthy weight.

In some cases, you might need medication prescribed by your doctor.

4. Cut down on alcohol

Too much alcohol can lead to weight gain and may increase your blood pressure.

Try to keep to a maximum of 14 units a week.

But spread it out to avoid binge drinking, and go several days a week without alcohol.

5. Stop smoking

If you smoke, your chance of getting diabetes and other serious health conditions is even higher.

Contact your GP if you experience the following:

Sex Secrets Prostitute who earns 2,000 a week reveals the average penis size ... and how much she enjoys work

Warning

'STOP FRYING YOUR SKIN' Brave mum posts graphic daily photos of her face as she battles skin cancer which 'ate away' at her forehead

HAPPY ST PADDY'S DAY Guinness IS good for you - and here's six surprising reasons why

Home remedies What causes mouth ulcers and how to treat them with stuff you have at home

NOT JUST SPOTS! Six common types of bumps on your skin - and the ones that could be deadly

FIRST EVER 'CURE' FOR BALDNESS Fresh hope for millions as new drug stimulates regrowth of a full head of hair in just FOUR MONTHS, experts claim

Dr Faye Riley, from Diabetes UK, said: Type 2 diabetes is serious, and this research stresses the particularly dangerous nature of the condition in those diagnosed at a younger age.

So with numbers risingwe have to stop this upward trend and the potentially devastating consequences.

A spokesperson for the NHS said: Families and other parts of society must step up as part of what needs to be a concerted effort to tackle the growing obesity epidemic.

What is type 2 diabetes?

Type 2 diabetes is the more common form of the disease - accounting for between 85 and 95 per cent of all cases, according to Diabetes UK.

It develops when the insulin-producing cells in the body are unable to produce enough insulin.

It can also be triggered when the insulin that is produced doesn't work properly.

Go here to see the original:
Number of young people with diabetes rockets by THIRD due to obesity crisis - The Sun

The unnecessary cost of diabetes has been revealed by a new study which found 10 per cent of the NHS hospital budget is being spent on avoidable treatment.

Approximately 3 billion a year may be going towards care that may have been avoided if patients and doctors had managed symptoms better, the analysis found.

It suggests that nearly four in ten diabetics are unable to keep on top of their blood-glucose levels, prompting emergency visits to hospital, as well as long and costly complications when being treated for other conditions.

On average, people with Type 2 diabetes - which is linked to obesity - need care costing over twice as much - 1,291 per person per year - as people without diabetes - 510 - an the 2017/18. Meanwhile with Type 1 diabetes, which usually develops in childhood, require six times more hospital treatment, at 3,035 per person per year.

The findings are being presented at the European Association for the Study of Diabetes (EASD) annual meeting in Barcelona.

Researchers analysed data on planned care as well as A&E visits, emergency hospital admissions and outpatient visits for 58 million people including 2.9 million with Type 2 diabetes and 243,000 with Type 1.

Overall, the NHS in England spent around 5.5 billion on hospital care for people with diabetes, of which an estimated 3 billion could potentially have been avoided, the team said.

They say this represents almost 10 per cent of the NHS hospital budget.

Read more from the original source:
NHS spends 3 billion in 'avoidable' treatments for diabetes each year - The Telegraph